The expression of PD-L1 in LECs is upregulated by the secretion of IFN-γ from tumor stromal cells, tissue-infiltrating antigen-specific CD8+ T cells, and so on; consequently, LECs inhibit T-cell accumulation in tumors [127,128]. The gene discussed is CD8A; the disease is neoplasm.